BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28239949)

  • 1. Temporal trends in peripheral arterial interventions: Observations from the blue cross blue shield of michigan cardiovascular consortium (BMC2 PVI).
    Thomas MP; Jung Park Y; Grey S; Schreiber TL; Gurm HS; Leffler D; Davis TP; Henke P; Michael Grossman P
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):728-734. PubMed ID: 28239949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of sex on morbidity and mortality rates after lower extremity interventions for peripheral arterial disease: observations from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
    Jackson EA; Munir K; Schreiber T; Rubin JR; Cuff R; Gallagher KA; Henke PK; Gurm HS; Grossman PM
    J Am Coll Cardiol; 2014 Jun; 63(23):2525-2530. PubMed ID: 24747101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Anemia With Outcomes in Patients Undergoing Percutaneous Peripheral Vascular Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2 VIC).
    Ambulgekar NV; Grey SF; Rosman HS; Othman H; Davis TP; Nypaver TJ; Schreiber T; Yamasaki H; Lalonde TA; Henke PK; Gurm HS; Mehta RH; Grossman PM;
    J Invasive Cardiol; 2018 Jan; 30(1):35-42. PubMed ID: 29289948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of contemporary percutaneous peripheral arterial interventions in the elderly insights from the BMC2 PVI (Blue Cross Blue Shield of Michigan Cardiovascular Consortium Peripheral Vascular Intervention) registry.
    Plaisance BR; Munir K; Share DA; Mansour MA; Fox JM; Bove PG; Riba AL; Chetcuti SJ; Gurm HS; Grossman PM;
    JACC Cardiovasc Interv; 2011 Jun; 4(6):694-701. PubMed ID: 21700256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association of Peri-Procedural Blood Transfusion with Morbidity and Mortality in Patients Undergoing Percutaneous Lower Extremity Vascular Interventions: Insights from BMC2 VIC.
    Henke PK; Park YJ; Hans S; Bove P; Cuff R; Kazmers A; Schreiber T; Gurm HS; Grossman PM
    PLoS One; 2016; 11(11):e0165796. PubMed ID: 27835656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quality and impact of risk factor control in patients with stable claudication presenting for peripheral vascular interventions.
    Ardati AK; Kaufman SR; Aronow HD; Nypaver TJ; Bove PG; Gurm HS; Grossman PM
    Circ Cardiovasc Interv; 2012 Dec; 5(6):850-5. PubMed ID: 23233746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional variation in patient selection and treatment for lower extremity vascular disease in the Vascular Quality Initiative.
    Soden PA; Zettervall SL; Curran T; Vouyouka AG; Goodney PP; Mills JL; Hallett JW; Schermerhorn ML;
    J Vasc Surg; 2017 Jan; 65(1):108-118. PubMed ID: 27692467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-induced nephropathy in patients undergoing endovascular peripheral vascular intervention: Incidence, risk factors, and outcomes as observed in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
    Grossman PM; Ali SS; Aronow HD; Boros M; Nypaver TJ; Schreiber TL; Park YJ; Henke PK; Gurm HS
    J Interv Cardiol; 2017 Jun; 30(3):274-280. PubMed ID: 28370487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary percutaneous coronary intervention at centers with and without on-site surgical support: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    Afana M; Gurm HS; Seth M; Frazier KM; Fielding S; Koenig GC
    Am Heart J; 2018 Jan; 195():99-107. PubMed ID: 29224652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radial PCI and the obesity paradox: Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    McDonagh JR; Seth M; LaLonde TA; Khandewal AK; Wohns DH; Dixon SR; Gurm HS
    Catheter Cardiovasc Interv; 2016 Feb; 87(2):211-9. PubMed ID: 26010906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of hybrid revascularization procedures for the therapy of multilevel lower extremity arterial disease--analysis of single center experience].
    Biroš E; Staffa R; Vlachovský R; Trnová-Chudárková M; Vojtíšek B; Suškevič I; Janoušová E
    Rozhl Chir; 2015 Sep; 94(9):372-8. PubMed ID: 26537102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization.
    Soden PA; Zettervall SL; Ultee KH; Landon BE; O'Malley AJ; Goodney PP; DeMartino RR; Arya S; Schermerhorn ML;
    J Vasc Surg; 2016 Dec; 64(6):1633-1644.e1. PubMed ID: 27575814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The disproportionate growth of office-based atherectomy.
    Mukherjee D; Hashemi H; Contos B
    J Vasc Surg; 2017 Feb; 65(2):495-500. PubMed ID: 27986487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of lesion location on procedural and acute angiographic outcomes in patients with critical limb ischemia treated for peripheral artery disease with orbital atherectomy: A CONFIRM registries subanalysis.
    Lee MS; Mustapha J; Beasley R; Chopra P; Das T; Adams GL
    Catheter Cardiovasc Interv; 2016 Feb; 87(3):440-5. PubMed ID: 26649816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding Complications in Lower-Extremity Peripheral Vascular Interventions: Insights From the NCDR PVI Registry.
    Bhardwaj B; Spertus JA; Kennedy KF; Jones WS; Safley D; Tsai TT; Aronow HD; Vora AN; Pokharel Y; Kumar A; Attaran RR; Feldman DN; Armstrong E; Prasad A; Gray B; Salisbury AC
    JACC Cardiovasc Interv; 2019 Jun; 12(12):1140-1149. PubMed ID: 31221303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroperitoneal hematoma after percutaneous coronary intervention: prevalence, risk factors, management, outcomes, and predictors of mortality: a report from the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) registry.
    Trimarchi S; Smith DE; Share D; Jani SM; O'Donnell M; McNamara R; Riba A; Kline-Rogers E; Gurm HS; Moscucci M;
    JACC Cardiovasc Interv; 2010 Aug; 3(8):845-50. PubMed ID: 20723857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal conduit choice in the absence of single-segment great saphenous vein for below-knee popliteal bypass.
    McPhee JT; Barshes NR; Ozaki CK; Nguyen LL; Belkin M
    J Vasc Surg; 2012 Apr; 55(4):1008-14. PubMed ID: 22365176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Readmission rates after lower extremity bypass vary significantly by surgical indication.
    Jones CE; Richman JS; Chu DI; Gullick AA; Pearce BJ; Morris MS
    J Vasc Surg; 2016 Aug; 64(2):458-464. PubMed ID: 27139788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of adjunct femoral endarterectomy in lower extremity bypass on perioperative and 1-year outcomes.
    Soden PA; Zettervall SL; Shean KE; Deery SE; Kalish JA; Healey CT; Kansal N; Schermerhorn ML;
    J Vasc Surg; 2017 Mar; 65(3):711-719.e1. PubMed ID: 27633166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endovascular intervention for peripheral artery disease.
    Thukkani AK; Kinlay S
    Circ Res; 2015 Apr; 116(9):1599-613. PubMed ID: 25908731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.